What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?

Reproduction

Volumn 130, Issue 3, 2005, Pages 283-291

  Rulli, Susana B ^a   Huntaniemi, Ilpo ^b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; TUMOR PROMOTER;

CLIMACTERIUM; ENDOCRINE FUNCTION; FERTILITY; GAMETOGENESIS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC MODEL; GENITAL SYSTEM DISEASE; GONAD DYSFUNCTION; GONAD FUNCTION; GONADOTROPIN RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS TUMOR; INFERTILITY; MENOPAUSE; MOUSE; NONHUMAN; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; REVIEW; TESTIS FUNCTION; TRANSGENIC MOUSE;

ANIMALS; CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; LUTEINIZING HORMONE; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; OVARY; REPRODUCTION; TESTIS;

MUS MUSCULUS;

EID: 24944532006     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.00661     Document Type: Review

References (70)

1. Ahtiainen P, Rulli S, Pelliniemi LJ, Toppari J, Poutanen M & Huhtaniemi I 2005 Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level; a study on hCG overexpressing transgenic mice. Oncogene In Press.
2. Allan CM, Garcia A, Spaliviero J, Zhang FP, Jimenez M, Huhtaniemi I & Handelsman DJ 2004 Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action. Endocrinology 145 1587-1593.
3. Amsterdam A & Selvaraj N 1997 Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumour suppressor genes. Endocrine Reviews 18 435-461.
4. Ascoli M, Fanelli F & Segaloff DL 2002 The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocrine Reviews 23 141-174.
5. Britt KL, Drummond AE, Dyson M, Wreford NG, Jones ME, Simpson ER & Findlay JK 2001 The ovarian phenotype of the aromatase knockout (ArKO) mouse. Journal of Steroid Biochemistry and Molecular Biology 79 181-185.
6. Burger LL, Haisenleder DJ, Dalkin AC & Marshall JC 2004 Regulation of gonadotropin subunit gene transcription. Journal of Molecular Endocrinology 33 559-584.
7. Burns KH & Matzuk MM 2002 Minireview: genetic models for the study of gonadotropin actions. Endocrinology 143 2823-2835.
8. Clevenger CV, Furth PA, Hankinson SE & Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocrine Reviews 24 1-27.
9. Cole LA & Butler S 2002 Detection of hCG in trophoblastic disease. The USA hCG reference service experience. Journal of Reproductive Medicine 47 433-444.
10. Conti M, Harwood JP, Hsueh AJ, Dufau ML & Catt KJ 1976 Gonadotropin-induced loss of hormone receptors and desensitization of adenylate cyclase in the ovary. Journal of Biological Chemistry 251 7729-7731.
11. Couse JF, Bunch DO, Lindzey J, Schomberg DW & Korach KS 1999a Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology 140 5855-5865.
12. Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ & Korach KS 1999b Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 286 2328-2331.
13. Delvigne A & Rozenberg S 2002 Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update 8 559-577.
14. Dufau ML, Cigorraga S, Baukal AJ, Sorrell S, Bator JM, Neubauer JF & Catt KJ 1979 Androgen biosynthesis in Leydig cells after testicular desensitization by luteinizing hormone-releasing hormone and human chorionic gonadotropin. Endocrinology 105 1314-1321.
15. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB & Korach KS 1996 Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137 4796-4805.
16. Fevold SL, Hisaw FL & Leonard SL 1931 The gonad-stimulating and the luteinizing hormones of the anterior lobe of the hypophysis. American Journal of Physiology 97 291-301.
17. Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao ChV, Tesarik J & Zygmunt M 2005 Novel concepts of human chorionic gonadotropin; reproductive system interactions and potentials in the management of infertility. Fertility and Sterility In Press.
18. Flaws JA, Abbud R, Mann RJ, Nilson JH & Hirshfield AN 1997 Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biology of Reproduction 57 1233-1237.
19. Franks S & McCarthy M 2004 Genetics of ovarian disorders: polycystic ovary syndrome. Reviews of Endocrine and Metabolic Disorders 5 69-76.
20. Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiology Reviews 80 1523-1631.
21. Gaytan F, Pinilla L, Romero JL & Aguilar E 1994 Differential effects of the administration of human chorionic gonadotropin to postnatal rats. Journal of Endocrinology 142 527-534.
22. Gnagy S, Ming EE, Devesa SS, Hartge P & Whittemore AS 2000 Declining ovarian cancer rates in US women in relation to parity and oral contraceptive use. Epidemiology 11 102-105.
23. Gromoll J, Simoni M & Nieschlag E 1996 An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. Journal of Clinical Endocrinology and Metabolism 81 1367-1370.
24. Huhtaniemi IT & Themmen APN 2005 Mutations in human gonadotropin and gonadotropin receptor genes. Endocrine In Press.
25. Huhtaniemi I, Zhang FP, Kero J, Hamalainen T & Poutanen M 2002 Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Molecular and Cellular Endocrinology 87 49-56.
26. Huhtaniemi I, Rulli S, Ahtiainen P & Poutanen M 2005 Multiple sites of tumorigenesis in transgenic mice overproducing hCG. Molecular and Cellular Endocrinology 234 117-126.
27. Huirne JA & Lambalk CB 2001 Gonadotropin-releasing hormone-receptor antagonists. Lancet 358 1793-1803.
28. Jameson JL & Hollenberg AN 1993 Regulation of chorionic gonadotropin gene expression. Endocrine Reviews 14 203-221.
29. Kananen K, Rilianawati, Paukku T, Markkula M, Rainio EM & Huhtanemi IT 1997 Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/simian virus 40 T antigen fusion gene. Endocrinology 138 3521-3531.
30. Keri RA, Lozada KL, Abdul-Karim FW, Nadeau JN & Nilson JH 2000 Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition. PNAS 97 383-387.
31. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA & Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. Journal of Clinical Investigation 105 633-641.
32. Konishi I, Kuroda H & Mandai M 1999 Review: gonadotropins and development of ovarian cancer. Oncology 57 45-48.
33. Kumar TR, Wang Y & Matzuk MM 1996 Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 137 4210-4216.
34. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC & Matzuk MM 1999 Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Molecular Endocrinology 13 851-886.
35. Kumar TR 2005 What have we learned about gonadotropin function from gonadotropin subunit and receptor mice? Reproduction 130 293-302.
36. La Vecchia C 2001 Epidemiology of ovarian cancer: a summary review. European Journal of Cancer Prevention 10 125-129.
37. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA & Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. New England Journal of Medicine 341 1731-1736.
38. Mann RJ, Keri RA & Nilson JH 1999 Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure. Endocrinology 140 2592-2601.
39. Mann RJ, Keri RA & Nilson JH 2003 Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Progress in Hormone Research 58 343-375.
40. Marshall JC, Eagleson CA & McCartney CR 2001 Hypothalamic dysfunction. Molecular and Cellular Endocrinology 183 29-32.
41. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ & Bradley A 1992 Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360 313-319.
42. Matzuk MM, DeMayo FJ, Hadsell LA & Kumar TR 2003 Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biology of Reproduction 69 338-346.
43. Meehan TP, Harmon BG, Overcast ME, Yu KK, Camper SA, Puett D & Narayan P 2005 Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. Journal of Molecular Endocrinology 34 489-503.
44. Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M & Huhtaniemi I 2003 High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene 22 3269-3278.
45. Mutter GL 1997 Role of imprinting in abnormal human development. Mutation Research 396 141-147.
46. Narayan P, Gray J & Puett D 2002 Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Molecular Endocrinology 16 2733-2745.
47. Owens GE, Keri RA & Nilson JH 2002 Ovulatory surges of hCG prevent hormone-induced granulosa cell tumor formation leading to the identification of tumor-associated changes in the transcriptome. Molecular Endocrinology 16 1230-1242.
48. Quigley CA 2002 Editorial: the postnatal gonadotropin and sex steroid surge - insights from the androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 87 24-28.
49. Pakarainen T, Zhang F-P, Poutanen M & Huhtaniemi I 2005 Fertility in LH receptor knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal LH action. Journal of Clinical Investigation In Press.
50. Richter-Unruh A, Wessels HT, Menken U, Bergmann M, Schmittmann-Ohters K, Schaper J, Tappeser S & Hauffa BP 2002 Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. Journal of Clinical Endocrinology and Metabolism 87 1052-1056.
51. Riman T, Nilsson S & Persson IR 2004 Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstetrica et Gynecologica Scandinavica 83 783-795.
52. Risbridger GP, Robertson DM & de Kretser DM 1982 The effects of chronic human chorionic gonadotropin treatment on Leydig cell function. Endocrinology 110 138-145.
53. Risch HA 1998 Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. Journal of the National Cancer Institute 90 1774-1786.
54. Risma KA, Clay CM, Nett TM, Wagner T, Yun J & Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. PNAS 92 1322-1326.
55. Risma KA, Hirshfield AN & Nilson JH 1997 Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology 138 3540-3547.
56. Roberts JE, Spandorfer S, Fasouliotis SJ, Lin K & Rosenwaks Z 2005 Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma. Fertility and Sterility 83 208-210.
57. Rulli SB, Kuorelahti AI, Karaer O, Pelliniemi L, Poutanen M & Huhtaniemi IT 2002 Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143 4084-4095.
58. Rulli SB, Ahtiainen P, Makela S, Toppari J, Poutanen M & Huhtaniemi I 2003 Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology 144 4980-4990.
59. Salbenblatt JA, Bender BG, Puck MH, Robinson A, Faiman C & Winter JS 1985 Pituitary-gonadal function in Klinefelter syndrome before and during puberty. Pediatric Research 19 82-86.
60. Schomberg DW, Couse JF, Mukherjee A, Lubahn DB, Sar M, Mayo KE & Korach KS 1999 Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 140 2733-2744.
61. Scott IS, Charlton HM, Cox BS, Grocock CA, Sheffield JW & O'Shaughnessy PJ 1990 Effect of LH injections on testicular steroidogenesis, cholesterol sidechain cleavage P450 mRNA content and Leydig cell morphology in hypogonadal mice. Journal of Endocrinology 125 131-138.
62. Simoni M, Gromoll J & Nieschlag E 1997 The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews 18 739-773.
63. Smith PE & Engle ET 1927 Experimental evidence of the role of anterior pituitary in development and regulation of gonads. American Journal of Anatomy 40 159-161.
64. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G & Costagliola S 2003 Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. New England Journal of Medicine 349 760-766.
65. Stenman UH, Alfthan H & Hotakainen K 2004 Human chorionic gonadotropin in cancer. Clinical Biochemistry 37 549-561.
66. Strauss BL, Pittman R, Pixley MR, Nilson JH & Boime I 1994 Expression of the beta subunit of chorionic gonadotropin in transgenic mice. Journal of Biological Chemistry 269 4968-4973.
67. Themmen APN & Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 21 551-583.
68. Themmen APN 2005 An update of the pathophysiology of human gonadotrophin subunit and receptor mutations and polymorphisms. Reproduction 130 263-274.
69. Ulbright TM 2004 Gonadal teratomas: a review and speculation. Advances in Anatomy and Pathology 11 10-23.
70. Vasseur C, Rodien P, Beau I, Desroches A, Gerard C, de Poncheville L, Chaplot S, Savagner F, Croue A, Mathieu E, Lahlou N, Descamps P & Misrahi M 2003 A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. New England Journal of Medicine 349 753-759.